The Funding Opportunities section provides a list of external funding opportunities available to our Researchers, Graduate Students & Postdoctoral Fellows and Undergraduate Students.  If you have any questions regarding external funding opportunities please contact Mike Folinas or Sam D’Alfonso.

All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal.

Additional comprehensive funding opportunities are available here:

Researchers

Canadian Liver Foundation - 2020 Operating Grants

Operating grants are for the support of research projects directed towards a defined objective, conducted by an investigator working alone or in collaboration with others. These grants may be used to purchase materials, supplies and items of equipment costing less than $5,000, to buy and maintain animals, and to support travel costs (to a limit of $1,000).

In 2020, three operating grants may be awarded:
One operating grant may be awarded to a researcher in Canada whose research project is related to hepatobiliary research. One operating grant may be awarded to a researcher in Canada whose research project is related to hepatitis B. One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer.

 

In recognition of the CLF’s varying calls for applications which may include specific designations for type of liver disease or a geographic location or have no designations and be open to all types and locations for hepatobiliary research, CLF operating grant applicants are asked to select and apply to one category per grant and identify their selected grant category on the application form.

The number of awards presented in any given year will be dependent on the number of suitable applicants and the funds available.

Award Amounts & Duration: $60,000 per year for two years

Deadline: May 29, 2020

Eligibility
Investigators with primary research interest in liver disease who hold an academic appointment in a Canadian university or affiliated institution are eligible to apply Clinical investigators and basic scientists will be considered

  • Applicants for operating grants must be members of the Canadian Association for the Study of the Liver (CASL)
  • Canadian citizens, landed immigrants and permanent residents will receive first consideration.

The Foundation reserves the right not to make an award in any year in which the above criteria are not fulfilled.

Submission Documents:
Operating Grant Application Form
Operating Grant CV Form
Guidelines
Cancer Research Society: Translational Research Partnership Program

The goal of this program is to support collaborative and pivotal translational research projects. Amount: Up to a maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society. Projects must be translational research and may include clinical trial studies, aim the development of a therapeutic and/or novel technologies, and have excellent preliminary data to support the proposed project. Letters of Intent from applicants with high potential projects will be invited to submit an official application for funding, which is then peer-reviewed.

There is no deadline associated with this program.

CanCOVID - New Canada-wide COVID-19 collaboration network: Accepting registrations

CanCOVID is an expert network  of Canadian COVID-19 researchers, clinical collaborators, and healthcare stakeholders from across the country. It is accepting registrations from recognized experts in the COVID-19 research and response community, including the following areas:

  • Diagnostics
  • Vaccines & Therapeutics
  • Modelling
  • Fundamental Science
  • Clinical trials
  • Cohort studies
  • Social & behavioural sciences
  • Healthcare
  • Policy decision-making
  • Indigenous knowledge
  • Medical devices
  • Patient services
  • Community health

The CanCOVID network membership is by invitation. To be considered a recognized expert, you must have professional affiliation with a university, hospital, clinic, government office, non-profit association or business. All prospective members will be vetted, including verifying email addresses and professional affiliations.

Post Doctoral and PhD Trainees will qualify for membership ONLY if serving as representatives for faculty supervisors who are actively researching COVID-19, or if they can demonstrate substantial prior research experience on COVID-relevant topics.

Researchers who meet the above criteria can register to join the network at https://cancovid.ca/#join.

Please do not register if you do not meet the above criteria. Limiting membership in this way will enable COVID-19 researchers to focus on critical research without distraction. It will also enable the platform administrators to focus their efforts on supporting core platform activities.

Canada’s Chief Science Officer mandated the creation of CanCOVID to  expedite communication and collaboration between the scientific, healthcare and policy communities during the COVID-19 crisis. The CanCOVID networkis designed to support collaboration, coordination and communication between scientists, clinical collaborators, funding agencies, government policy makers, and healthcare practitioners. CanCOVID is linking up Canada’s research network using Slack, an online messaging and collaboration platform. Volunteers are available to help members who are new to Slack; you can indicate your need for Slack assistance on the registration form.

For more information, visit the CanCOVID website https://cancovid.ca/ or follow us on Twitter @CanCOVID.

CRIS Spotlight: Resources for Researchers during the COVID-19 Pandemic

CRIS Spotlight: Resources for Researchers during the COVID-19 Pandemic 

In response to the COVID-19 pandemic, the Centre for Research & Innovation Support (CRIS) has curated a set of resources for researchers. This new Spotlight page highlights specific resources to support researchers during this exceptional period. The Spotlight page currently features technology and training on working remotely; highlights online professional development opportunities; and provides links to COVID-19 information for faculty from various sources at the University. This page will be updated regularly to respond to the needs of our community.

To sign up to receive future email communications from CRIS, including new Spotlight resources, please click here.

Background

The Centre for Research & Innovation Support (CRIS) is a newly established resource hub for University of Toronto researchers. The Centre was established in 2019 as a partnership between the Division of the Vice-President, Research & Innovation, U of T Libraries, and Information Technology Services.  CRIS’s main objective is to help researchers to navigate the vast array of existing resources while partnering to address emerging unmet needs. 

To get in touch with the CRIS team, please email us at: cris@utoronto.ca or follow us on Twitter: @CRIS_UofT

Employment and Social Development Canada – Sustainable Development Goals Funding Program – Grants

In 2015, Canada and all other United Nations Member States, committed to implementing the 2030 Agenda for Sustainable Development, which set 17 Sustainable Development Goals (SDGs) to eliminate poverty, protect the planet and ensure prosperity by the year 2030.  Applications are currently being accepted, on an ongoing basis, from organizations interested in receiving up to $100,000 in grant funding from the SDG Funding Program for projects that are up to 12 months in duration.
Sponsor Deadline: Ongoing

Federal COVID-19 Immunity Task Force Seeks Information on COVID-19 Studies

The COVID-19 Immunity Task Force has a mandate to identify how many Canadians have been exposed to the SARS-CoV-2 virus and determine the degree and duration of immunity.  As part of its due diligence, the Task Force is undertaking a rapid landscaping survey that is seeking to identify individuals and organizations that are either leading COVID-19 related studies or have established infrastructure that could potentially engage in its work.  

For example, this includes studies or services that:

Survey general populations and collect biological specimens; Examine specific populations at defined parts of the life course such as antenatal, Children/youth, adults, elderly; by occupation such as health care workers, long term care workers or first responders, or by markers of vulnerability such as incarcerated, the homeless or persons living with co-morbidities; Engage Indigenous Peoples, First Nations (on/off reserve), Inuit, Metis, and non-status First Nations

https://www.covid19immunitytaskforce.ca/survey-for-key-informants-understanding-opportunities-to-assess-covid-19-immunity-in-canada/

Also, if you have not already done so, please take advantage of COVID-19 information and collaborative resources available and the UofT Centre for Research & Innovation Support (CRIS) website

If your are leading such studies or services, please  complete the brief survey questionnaire:

IDEaS COVID-19 Challenge Launch

As part of the larger pan-government response to the COVID-19 pandemic, the Innovation for Defence Excellence and Security (IDEaS) program is participating in a multi-departmental initiative seeking innovative solutions to help in the fight.

The below challenges are focused on improving disease tracking and likely exposure to COVID-19 using data analytics as well as making sure those on the front lines have a safe operating environment through a combination of better decontamination technology and improved personal protective equipment.

The following challenges are now available:

Rapid response: Real-time insights for pandemic decision-making

Scrubbing your scrubs: Finding ways to re-use COVID-19 protective gear

Super sanitize: Cleaning sensitive equipment and workspaces

Funding

Competitive Projects using Contributions is divided into two phases: Phase 1 that awards up to $200,000 for a period of 6 months, and Phase 2 that awards up to $1,000,000 for a period of 1 year.

This Call for Proposals is for Phase 1 only.

Phase 1 – award up to $200,000

The objective of Phase 1 is to establish the S&T merit, innovativeness and impact of a solution that addresses a specific S&T Challenge. Applicants propose a solution within SRL 1-6 (inclusive). Proposals are evaluated and solutions that meet the evaluation criteria and all other requirements may be recommended for funding. If selected, applicants are eligible to receive up to $200,000 per agreement for the development of their proposed solution for a maximum performance period of six months.

Phase 2 – award up to $1,000,000

The objective of Phase 2 is to continue the S&T efforts of Phase 1 and progress promising solutions to a higher SRL. Applicants of successful Phase 1 solutions may receive an invitation from DND to further their solution’s SRL continuum and would be requested to submit a proposal (form to be supplied by DND at the appropriate time). Proposals will be evaluated and if selected, applicants are eligible to receive up to $1,000,000 per agreement for the development of their proposed solution for a maximum performance period of one year.

Participation in Phase 2 is not guaranteed and is not mandatory. Application information for Phase 2 will be made available to applicants that have successfully completed Phase 1 projects and are invited to submit a Phase 2 proposal. 

Application Process and Key Dates

This Call for proposals (CFP) invites proposals for Phase 1 only and involves a three-stage funding process. The steps of for each stage are summarized below to better illustrate the overall process. For more information, please visit the IDEaS Program Applicant Guide

Stage 1

Stage 2

Stage 3

Proposal Submission

Proposal Evaluation & Selection

Contribution Agreement Awarded

Applicant is to complete and submit a proposal form.

The Applicant is to complete the following:

  1. Review the S&T Challenges and determine if they can address any of them with an innovation.
  2. Complete the Proposal Form and submit on or before the closing date for the CFP.

DND will evaluate the submitted proposals and select.

Those selected are awarded a contribution agreement.

Deadline
Stage 1 CFP Application deadline: June 23, 2020 at 14:00 EDT.

Additional Resources

For more information about the program, please visit: https://www.canada.ca/en/department-national-defence/programs/defence-ideas/understanding-ideas/sandbox/covid19-challenges.html

Please contact DND.IDEaS-IDEeS.MDN@forces.gc.ca for questions related to the program. DND IDEaS will also be hosting an information session to answer questions about the application process or any technical questions. Details and registration for the information session can be found here.


 
 
International Doctoral Cluster (IDC) Applications

An International Doctoral Cluster (IDC) is a research and doctoral education arrangement in a well-defined area/topic of research that brings together, through in-person and virtual activities, a critical mass of complementary talent (PIs, PDFs and graduate students).  An IDC is a partnership between faculty and trainees at U of T and international partner institutions (academic/corporate/NGO etc.) in the form of an alliance that is more than the sum of its parts.

We are inviting IDC proposals which support cross-disciplinary and cross-border collaborations to catalyze new ideas and transformational innovations.

Taking into account the changing ways in which collaborative research is being conducted, the IDC program will give strong consideration to proposals that aim to develop robust international research and training opportunities and networks through a combination of in-person, virtual, and other novel approaches to global collaborations.

Funding and Duration:

  • The Office of the Vice-President International (OVPI) and the School of Graduate Studies (SGS) will together provide one third of the budget, up to a maximum of $33,000 CAD/year for the associated mobility costs for U of T students, PDFs, and faculty, for up to 3 years initially.  The IDC will be subjected to an internal review and if there is a good case to be made for a longer period of funding, could be renewed for a maximum of two further years.
  • The funding may also be used to cover the costs of novel virtual approaches to global collaborations, such as the use of online communication platforms, virtual workshops and lab group meetings, virtual journal clubs, and online open access lab notebooks.  Please contact OVPI for more information/questions concerning this.
  • PIs should secure the remaining 2/3rd from within and beyond the University (e.g. Tri-Agency, industry, philanthropy, etc.).

Application Deadline: February 15, May 15, September 15, and December 15.
Notification to Successful Applicants: Decisions will be communicated within 8 weeks of submission.
Eligibility: U of T applicants must have a faculty appointment with U of T and be eligible to hold research funding.

Selection Criteria:
   1. Proposed academic case including research strength, design, and rationale
   2. Engagement of a critical mass of PIs at U of T & overseas and complementarity amongst all co-PIs

   3. Proposed implementation plan, including for graduate training
   4. Novelty of approaches used in implementation plan
   5. Desired outcomes: knowledge transfer, attract top global talent, multidisciplinary global knowledge networks
   6. Funding: leverage larger sources of external funding to sustain partnership
   7. Enhance global exposure of U of T community
 

For more information on this call, including detailed instructions on how to submit a proposal, please see the funding opportunities page.

Contact: Skandha Sunderasen, International Strategic Partnerships Officer (s.sunderasen@utoronto.ca) for any questions about the IDC call and to submit IDC applications.
MDC - Psychiatry Consortium: Validation of Novel Molecular Drug-targets

The Medicines Discovery Catapult (MDC), representing a consortium of charities and global pharmaceutical companies (“Psychiatry Consortium”), is looking for proposals that focus on the validation of novel molecular drug-targets.

The Psychiatry Consortium will work collaboratively with successful researchers to develop the projects and provide, in addition to project funding, access to drug-discovery expertise, drug-discovery capabilities through specialised Partner Organisations, commercial know-how, and project management resources.

Scope
The Psychiatry Consortium is seeking project proposals which focus on the validation of novel molecular drug-targets for the following mental health conditions:
psychotic disorders, bipolar disorder, depression, anxiety, stress-related disorders, PTSD, OCD, autism spectrum disorders as well as psychiatric symptoms associated with dementia and other cognitive disorders

The Psychiatry Consortium intend to fund projects which:

  • show some evidence that links the molecular target to human disease and of the target modulation having a therapeutic effect, which can be further developed or validated
  • will enable tools for target validation e.g. through optimisation of existing tool compounds to improve selectivity, potency, bioavailability

Funding
Projects will be expected to last up to 3 years and the total eligible funding will be between £200,000 and £1,000,000, depending on the specific requirements of each project.

Application Process
The call for applications for project funding will run twice per year;

For 2020 the call dates will be:

  • Call 2 Open: April 27th | Deadline: June 12th
  • Call 3 Open: October 5th | Deadline: November 20th

Before submitting your application, please read their Terms and Conditions. You may also find their FAQs useful.

For more information and to apply, please visit: https://psychiatryconsortium.org/call-for-proposals/
Projects seeking to identify target modulation biomarkers relevant to disease will also be in scope.

Merck KGaA Research Grants

Stimulating Innovative Research

In 2020, Merck KGaA  is offering a series of research grants to stimulate innovative research in challenging areas of future importance.
Grants of 100,000 EUR - 500,000 EUR per year for up to 3 years are available in the areas of:

  • Drug discovery 
  • Bioreactor design for cultured meat
  • Next generation machine learning
  • Pandemic preparedness / fighting new emerging viral infectious disease

Application Process

  • The research grants program is open to scientists in all career stages who are affiliated with any research-based institution, university or company.
  • Applicants submit their application for the focus topics containing non-confidential information only.
  • You may apply for more than one focus topic. If your application is successful, you will be invited to submit a full proposal and join a deep-dive workshop with the other finalists in 2020.  

To submit an application, researchers must first register with Merck’s online portal. On your first visit, you will need to register (click "register" in the online form) with a valid email address. Your registration link will then be forwarded to this email address.

Deadlines

Application submission deadline for the Drug discovery, Bioreactor design, Next generation machine learning topics is August 31, 2020, 5:59 p.m. EST.

There is no fixed deadline for the Pandemic preparedness topic as it will be reviewed on a rolling basis to provide a quicker response. 

Mitacs: Special Mitacs internships during COVID-19 - Call for Applications

Mitacs links companies, organizations, networks, researchers for COVID-19 solutions

From improving masks to developing a vaccine, Mitacs is rapidly deploying resources to mobilize Canadian researchers to develop solutions to the COVID-19 coronavirus pandemic.

In response to the Government of Canada’s and provinces’ announcements of funding for coronavirus research, Mitacs’s team of business development experts are available to connect businesses and not-for-profit organizations with talent, equipment, and expertise in the post-secondary education system to develop innovative solutions.

Mitacs special COVID Accelerate stream is open and accepting applications.

This rapid-response stream is limited to 200 internships nationally (https://www.mitacs.ca/en/newsroom/news-release/mitacs-links-companies-organizations-networks-researchers-covid-19-solutions).

The main unique requirements/features for this Accelerate funding are as follows:

  1. Must involve an SME (<500 employees)
  2. Projects must address COVID-19
  3. Being a limited funding stream, potential projects must be vetted by a Mitacs Business Development representative prior to proceeding with an application
  4. Cash contribution from the SME will be reduced to $3,750+HST per 4 month internship unit
  5. Scientific decisions on these applications will be provided within 1-2 weeks

For COVID projects involving a large corporation, note that these Accelerate projects may still qualify for the special 1-2 week streamlined research review.

If you have additional questions, please contact Wil de Vega  C: 647-355-8542 wdevega@mitacs.ca

Mitacs Elevate – Postdoc Funding

Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Fellows address complex challenges through:

  • An exclusive research management curriculum for postdoctoral fellows in any discipline
  • A minimum one-year research project (normally two years in duration) with a partner organization in need of high-level expertise
  • A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value      
     

NEW: Mitacs now accepts cross-provincial Elevate applications, where the partner and university are in different provinces.

Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers.

Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor.

Elevate fellows receive:

  • $55,000 minimum annual stipend/salary  (of the $60,000 awarded to the University; $5,000 being available to the supervisor's account, to support the research)
  • Training curriculum valued at $7,500 per year
  • Submission assistance, including application feedback, from Mitacs representatives
  • Certificate of completion after receipt of their exit survey and final report submission

Key Deadlines:
 MITACS

  • Intent to Apply (non-mandatory) and Conflict of Interest Declaration (if applicable) - June 10, 2020
  • Application - July 22, 2020

INTERNAL:

Please note: By the internal deadline, the applicant must upload and submit the application through the university's My Research Application (MRA) System. The MRA approval process should be started well in advance of the internal deadline to ensure a successful submission since it can take several business days to complete the approval process.

MITACS - Enhanced leveraging for Canadian Small- and Medium-sized Enterprises (SMEs)

MITACS is expanding its support of Canadian Businesses

For a limited time, Mitacs is increasing their funding for SMEs to 75% of a project’s cost from the 50% they typically fund (some restrictions may apply).

1.    Enhanced leveraging for Canadian Small- and Medium-sized Enterprises (SMEs)

For a limited time, Mitacs will offer 3:1 cash leveraging on Accelerate projects involving a Canadian SME. The official landing page is here: https://discover.mitacs.ca/boost-funding-sme/

The eligibility criteria for an Accelerate application with this limited-offer model are as follows:

·       Company must be a for-profit, Canadian SME (<500 employees)

·       The project must start by August 31, 2020

The funding model for this Accelerate is $3,750+HST from the Canadian SME and $11,250 from Mitacs for a 4-6 month project. You may note that this the same as the previously-announced Accelerate COVID-19 funding stream. Mitacs hereby confirms that this new Canadian SME funding stream will support any type of R&D project and is not COVID-specific.

The deadline to submit all application materials to Mitacs is Wednesday, July 1, 2020.

For additional details, professors and industry partners are asked to contact their local Mitacs Business Development representative (https://www.mitacs.ca/en/contact-us/business-development).

National Research Council Canada: NRC COVID-19 response - Call for Expression of Interest

The Government of Canada is taking strong and quick action to protect our economy, and the health and safety of all Canadians during this global outbreak of the novel coronavirus (COVID-19).

Government of Canada is working with their partners as part of the collective effort to help find solutions to the COVID-19 outbreak.

NRC COVID-19 Challenge Program

Purpose: This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register using the button below to indicate their interest, and related areas of expertise and capabilities.

The NRC will receive $15M to form dedicated teams to address challenges in the areas of greatest research and development (R&D) need in the fight against COVID-19. The NRC Pandemic Response Challenge Program will accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians. This national vehicle will convene the best Canadian and international researchers from academia and small and medium-sized businesses to collectively accelerate R&D to address specific COVID-19 gaps and challenges as identified by Canadian health experts. The Pandemic Response Challenge Program is currently structured around 3 main research areas:
1. Rapid detection and diagnosis
2. Therapeutics and vaccine development
3. Digital health

In order to manage the University's response to the COVID-19 Challenge, please confirm your registration via a courtesy email to strat.initiatives@utoronto.ca identifying the Challenge stream to which you have registered.  As with other Challenges in relation to COVID-19, this is a rapidly evolving real-world situation, so please be patient as NRC finalizes program details.

Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise can now register their interest to work with NRC on these challenges by Registering via the link below.

On that linked page, you will be asked to identify your primary area of interest.  Please note that, as a 'radio button,' you can only select one Challenge area at a time.

Funding is available to help cover the costs of research for academic institutions, small and medium-sized businesses, and other eligible recipients participating in the challenge teams. Over the coming weeks, NRC will post the specific R&D challenges,  send information to registered researchers, and invite them to indicate the expertise and capabilities they can bring to a team.

https://nrc.canada.ca/en/research-development/research-collaboration/programs/expression-interest-challenge-program-collaboration

NIH POCTRN: Fast-Track Program for COVID-19 Test Development and Distribution

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.

NIBIB  is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to  clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution.

Design features might include technical innovations that:

  • Improve analytical performance, e.g., sensitivity, specificity, dynamic range, limit of detection, reliability, accuracy, speed (time to test result) and throughput
  • Enhance operational performance through, e.g., development of a patient- and user-friendly design, use of alternative sampling strategies (e.g., saliva, exhaled breath), integration with mobile-devices, designs for home-based use or strategies to overcome bottlenecks with current testing approaches
  • Improve access and reduce the cost of testing

 

Application Process:

 

Project proposals will be accepted through the online RADx portal on a rolling basis and will be reviewed within a week of receipt. 

Based on meritorious review, RADx will select projects for a 3-phase process (Phases 0, 1 and 2). Each phase will have a budget and deliverables that must be reached to move to the next phase.

  • Phase 0: Work Package Development. An external expert panel will rapidly review all project proposals submitted to RADx for program suitability and technology readiness level. Following review, if NIH accepts a project into the RADx program, project teams will initiate Phase 0, a “deep dive” with content and commercialization experts that produces a customized one- or two-phase work package.  Awards of up to $25,000 will be provided to cover the approximately one week participation in the RADx deep dive. Based on the results of this deep dive, a subset of projects will be selected for progression to Phase 1. More advanced approaches with higher technology readiness levels will be selected for acceleration directly to Phase 2.
  • Phase 1: Work Package #1. Once NIH approves a project for entry into phase 1, funding will be provided immediately to allow work to begin. Depending on the structure of the work package, some funding may be dependent on successful achievement of interim milestones. The awarded budget will be sufficient to address gating risks identified in Phase 0 on a maximally accelerated timetable. In-kind support may be provided in technical, clinical, manufacturing, and regulatory domains. Depending on the milestones that must be met, project budgets are expected to range from $500,000 to millions of dollars.
  • Phase 2: Work Package #2. The awarded milestone-driven budget will be sufficient to enable full product deployment on a maximally accelerated timeline. Additional accelerating resources will be made available through partnerships established by NIH and in-kind support provided by NIH and RADx.  For projects that meet all milestones toward product distribution, budgets of tens of millions of dollars are anticipated. NIH will negotiate cost sharing with for-profit institutions as appropriate.

 

 

For more information and to apply, please visit: https://www.poctrn.org/radx

FAQs about this program can be found here.

NIH Various Opportunities

The National Institutes of Health has released the following requests for applications and program announcements:
Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
(RFA-CA-20-009) Submission Deadlines: June 09, 2020; November 18, 2020

Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01) (RFA-DA-20-022) 
Application Receipt Date(s): AIDS Application Due Dates

Biomedical Knowledgebase (U24)
(PAR-20-097) Submission Deadline: September 25, 2020; January 25, 2021; September 24, 2021

Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01) (PAR-19-289).
Submission Deadline: Standard deadline dates apply.

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01) (PAR-19-325)
Submission Deadlines:  September 30, 2020.

Clinical Studies of Mental Illness (R01) (PAR-19-297)
Submission Deadline: Standard dates apply

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01) (PAR-19-325)
Submission Deadline: September 30, 2020.

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24) (PAR-19-330).
Submission Deadline: June 10, 2020, October 14, 2020.

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) (PAR-19-330).
Submission Deadlines: June 10, 2020, October 14, 2020.

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3)
(PAR-20-092).
Submission Deadlines: Applications will be accepted on a rolling basis, beginning on February 24 , 2020.  

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) (RFA-CA-20-007). Submission Deadlines : June 9, 2020; November 18, 2020

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
(RFA-CA-20-008) Submission Deadline: June 9, 2020; November 18, 2020

Ethical Issues in Translational Science Research (R01) (RFA-TR-20-001)
Application Receipt Date(s): October 6, 2020, and October 6, 2021

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (PAR-20-034).
Application Receipt Date(s): Standard dates apply.

Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01) (PAR-20-026).
Application Receipt Date(s): September 15, 2020, September 15, 2021

Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01)(PAR-20-027).
Application Receipt Date(s): September 15, 2020, September 15, 2021

Grand Opportunity in Medications Development for Substance-Use Disorders (U01) (PAR-19-327).
Submission Deadline: on a rolling basis, beginning on August 26, 2019

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (PAR-19-327).
Submission Deadlines: Applications will be accepted on a rolling basis, beginning on August 26, 2019

Human-Animal Interaction (HAI) Research (R01) (PAR-20-031)
Application Receipt Date(s): November 30, 2020; November 30, 2021

Human-Animal Interaction (HAI) Research (R03) (PAR-20-032)
Application Receipt Date(s): November 30, 2020

Human-Animal Interaction (HAI) Research (R21) (PAR-20-033)
Application Receipt Date(s): November 30, 2020;

Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3) (RFA-HL-20-025).
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s)

Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB-SIMPLe) Research Coordinating Center (U24) (RFA-HL-20-026)
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s)

Integrative Research on Polysubstance Abuse and Disorder (R61/R33)(PAR-20-035)
Application Receipt Date(s): July 17, 2020, November 17, 2020, March 17, 2021

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
(PAR-20-108) Submission Deadlines: July 15, 2020; July 15, 2021; July 15 2022

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01) (PAR-19-307)
Submission Deadline: January 14, 2021

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21)(PAR-19-364).
Only accepting applications for the AIDS Application Due Dates

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01) (PAR-19-357).
Submission Deadline: AIDS Application Due Dates

NCI Clinical and Translational Exploratory/Developmental Studies (R21) (PAR-19-356)
Submission Deadline: June 19, 2020; October 20, 2020

Neural Regulation of Cancer (R01) (PAR-19-353)
Submission Deadline: May 27, 2020; October 21, 2020

Neural Regulation of Cancer (R21) (PAR-19-354)
Submission Deadline: May 27, 2020; October 21, 2020;

NIA Multi-site Clinical Trial Implementation Grant (R01)  (PAR-19-302)
Submission Deadline: Standard dates apply

Non-Invasive Neurostimulation in AD/ADRD (R01) (PAR-19-298)
Submission Deadline: Standard dates apply

Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01) (PAR-20-053)
Application Receipt Date(s): Standard dates apply

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03) (PAS-19-391)
Application Receipt Date(s): Standard dates apply

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03) (PAS-19-392)
Application Receipt Date(s): Standard dates apply.

Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03) (PAS-19-393)
Application Receipt Date(s): Standard dates apply

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) (PAR-19-309)
Submission Deadline: Standard dates apply

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)(PAR-19-328)
Submission Deadlines: June 10, 2020

Single-Site Investigator-Initiated Clinical Trials (R61/R33) (PAR-19-328)
Submission Deadline: June 10, 2020
Application Receipt Date(s): July 17, 2020, February 13, 2021

Sustained Support for Informatics Technologies for Cancer Research and Management (U24)
(RFA-CA-20-010) Submission Deadline: June 09, 2020; November 18, 2020

Transgender People: Immunity, Prevention, and Treatment (R21) (PAR-20-054)
Application Receipt Date(s): May 11, 2021

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01) (RFA-MH-20-350)
Application Receipt Date(s): October 9, 2020; June 10, 2021

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21) (RFA-MH-20-351)
Application Receipt Date(s): October 9, 2020; June 10, 2021

Visit here to see the National Institutes of Health’s recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University’s Research Funding Opportunities found here.

NSERC Alliance grants: Canada’s Research Partnerships Program

NSERC is pleased to announce that Alliance grants are now open for all Option 1 requesting more than $20,000 annually from NSERC, and Option 2 applications requesting over $30,000 and up to $100,000 annually from NSERC.  For Option 2, the number of applications from each applicant (as principal investigator or as co-applicant) will be limited to one within a 12-month period. As with the staged Option 1 introduction in 2019, the full range of Option 2 applications will be accepted only at some point in future. Alliance Option 2 applications will be evaluated in two stages. Complete applications will be submitted to a multidisciplinary and multisectoral selection committee that will assess whether the higher NSERC contribution (associated with Option 2) is justified. The selection committee will meet on a quarterly basis, starting in the Spring of 2020. If selected, applications will then proceed to the second step for review of overall merit, similar to Option 1. NSERC personnel have been invited to present a workshop on optimizing Alliance applications on the downtown St. George campus in late March 2020. Details of this visit will be shared in a subsequent Research Alert.

For full details about Alliance grants and how to apply, please visit: http://www.research.utoronto.ca/research-funding-opportunities/natural-sciences-and-engineering-research-council-of-canada-alliance-grants/

Please consult the Alliance Latest News page and the updated Frequently Asked Questions for more information.

NSERC-Alliance COVID-19 Grants

NSERC, the Natural Sciences and Engineering Research Council, is launching an accelerated program (up to $15M total funding) to fund promising research into mitigating the COVID-19 pandemic.  Under an expedited version of its Alliance program, NSERC will provide funding of up to $50,000 for individual projects of up to one year duration; interdisciplinary partnerships are encouraged, but the main focus should not be on medical or clinical research.

In addition to Investigator-led projects, NSERC is soliciting ideas from potential partners, which will be shared with the academic community – details at the link below.

At least one partner (private-sector, public-sector, or not-for-profit) must be eligible for NSERC funding under standard Alliance rules; other partners, including those normally ineligible, may also collaborate on these projects.  Partners must be strongly engaged, but cash contributions are not mandatory under this limited program.

Internal deadline: any time prior to May 25, 2020

Sponsor deadline: any time prior to May 30, 2020

Visitors to the NSERC-Alliance COVID-19 website may have noticed a solicitation page for potential industry partners seeking academic expertise.  That site, with project requests from eligible industry partners, has now been launched.  Potential projects are identified by a brief description and the province of the prospective (anonymized) partner.  Interested academic research teams can now peruse the List of Prospective Projects seeking an academic partner.

Interested researchers are invited to self-identify via the link associated with each opportunity, supplying their name and email address.  NSERC will then effect the introduction to the originating partner.

General information about the NSERC-Alliance COVID-19 grant program can be found at: https://www.nserc-crsng.gc.ca/Innovate-Innover/COVID-19/index_eng.asp

Additional Resources:

PowerPoint presentation: Preparing an Alliance application (NEW)
PowerPoint presentation with notes: Preparing an Alliance application (NEW)
Alliance grant application checklist
Equity, diversity and inclusion in the training plan
Partner organization self-assessment tool

NSERC Funding for Science Communications Skills

NSERC Announces Funding for Science Communications Skills through a pilot funding opportunity to enhance the communications skills of students and researchers in the natural sciences and engineering. Such skills will contribute to science literacy, help counter science-related misinformation, and foster a role for science in evidence-based decision making.

The new pilot program is targeted at organizations that provide science communication skills training to STEM (science, technology, engineering and math) students, fellows, and faculty from Canadian post-secondary institutions. The training should have as its goal the effective communication of science to the general public. Organizations may request up to $20,000 in funding for a one year period.

NSERC encourages organizations to consider the needs of official language minority communities in their area while developing their proposed  activities and to have official documentation and promotional material in both official languages.

Key Deadlines:

Internal Deadline: June 11, 2020
Submit the following to the Research Services Office (RSO) on or before the specified internal deadline of 5:00 PM June 8, 2020:

A completed NSERC Science Communication Skills Grant (Pilot) Application Summary Form for RSO institutional authority signature. A completed My Research Application (MRA) with all required attachments  and approvals from your unit head or one-up, where applicable.  Be sure to include any required additional documentation required to support your application 

Sponsor Deadline: June 15, 2020
Submit the completed application electronically as follows directly to NSERC no later than 8:00 PM June 15, 2020:

Once the application is finalized and completed, combine all the parts of your application into a single document in Portable Document Format (PDF). Submit full application directly to NSERC via the Secure Submission Site for NSERC’s Innovative Collaborations and Science Promotion Programs  

NSERC Idea to Innovation (I2I)

Four times per year, the Natural Sciences and Engineering Research Council (NSERC) accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses.

Internal Application Deadline for Current Round: June 8, 2020
Sponsor Deadline: June 22, 2020

Please note: By the internal deadline, the applicant must upload and submit the application through the university's My Research Application (MRA) System. The MRA approval process should be started well in advance of the internal deadline to ensure a successful submission. Applications received after the internal deadline may impact IPO's ability to review and process your application prior to the NSERC deadline.

All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project.

For more information please contact IPO's intake email innovations.partnerships@utoronto.ca or visit NSERC's website at: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP-PP/I2I-INNOV_eng.asp

NSERC: Synergy Awards for Innovation - Call for Nominations

The Synergy Awards for Innovation honour outstanding research and development (R&D) partnerships between a university or a college, and industry, in the natural sciences and engineering. Since 1995, the Awards have showcased the value of pooling Canadian research excellence and Canadian industrial expertise to address challenges that provide tangible benefits to Canada.

Synergy Awards include three categories for universities and one category for colleges, to highlight the impact and lasting benefits of their applied R&D collaborations with industrial partners.

Winners of the Synergy Awards must show effective use of human, technical and financial resources, leading to tangible commercial, social or environmental benefits with their industrial partners. Universities must demonstrate a sustained partnership while colleges may focus on the impact of near-term applied research.

Synergy Awards are your opportunity to show the world what Canadian ingenuity and collaboration can accomplish.

Nomination deadline: June 1, 2020, 8:00 p.m. (ET)

For complete award information, please visit: https://www.nserc-crsng.gc.ca/Prizes-Prix/Synergy-Synergie/Nomination-Nomination_eng.asp
Ontario Centres of Excellence: Voucher for Innovation and Productivity - Open for expedited COVID-19 Applications (VIP)

The Voucher for Innovation and Productivity (VIP) program helps companies develop, implement and commercialize technical innovations by supporting partnerships between Ontario's industry and publicly funded post-secondary institutions. VIP projects are intended to generate economic benefit for companies in Ontario (including job creation/retention, new revenue generation, investment attraction, cost savings, value chain development).  For the COVID-19 variant, results are expected to provide tangible benefits immediately upon completion of the project.

OCE Funding for COVID-19: Between $20,000 and $100,000 to the post-secondary institution (minimum $20,000 per year)

Matching Requirement for COVID-19: Up to 2:1 cash from the Industry Partner

  • Minimum 50 per cent of the partner's cash contribution must be spent at the post-secondary institution; remainder may be spent at the company
  • Cannot be leveraged with other federal or provincial grant programs unless otherwise stated in this program guideline
  • For the COVID-19 Call for Submissions, OCE will consider alternate matching requirements, for OCE funding between $20,000 and $100,000 up to Thursday, May 28, 2020.

Project Duration for COVID-19: Up to 12 months

Program Status and Submission Deadline: Open for expedited COVID-19 Applications - due by Thursday, May 28, 2020

How to Apply: https://www.oce-ontario.org/programs/voucher-for-innovation-and-productivity-(vip)

For detailed program please visit: https://www.oce-ontario.org/programs/voucher-for-innovation-and-productivity-(vip)

For more information on the VIP Program, please contact:

Alexandra Ho
Program Manager
Tel: 416-861-1092 x5018
Email: Alexandra.Ho@oce-ontario.org  - for this special consideration please identify COVID-19 in the email title

Pfizer Global Medical Grants – COVID-19 Funding Opportunity: Call for Proposals

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Specific Area of Interest: The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. They are particularly interested in supporting research in the following areas:

Understand impact of COVID on communities, spectrum of disease in communities, and level of herd immunity Postmortem Analysis of deceased persons with known or suspected COVID-19

Eligibility
Only organizations are eligible to receive grants, not individuals or medical practice groups.  The applicant (PI) must be affiliated with a host institution and must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

Funding
Expected approximate range of grant awards: $50,000 to $250,000 USD. Pfizer will consider larger grants depending on the size and scope of the program.

Important Dates
Internal deadline: June 10, 2020
Sponsor deadline: June 17, 2020

Pfizer will aim to review all applications in a 10 to 14 day period, but processing time but may take longer for organizations outside of the U.S. Resarchers are recommended to apply well in advance of the deadline as the program is anticipated to generate a high volume of applications. 

Application Process
Please go to www.cybergrants.com/pfizer/Research and sign in. First time users should click “Create your password”.  In the application:  For the question “Are you replying to a Request for Proposal as part of the Competitive Grant Program?” select Yes

  • Select the following Competitive Grant Program Name: 2020 VAC G - Vaccine Preventable Diseases – COVID-19
  • Select the following Primary Area of Interest: Vaccine Preventable Diseases – COVID-19
Requirements for submission: Complete all required sections of the online application and upload your project proposal in the Proposal/Protocol field. If you encounter any technical difficulties with the website, please click the “Technical Questions” link at the bottom of the page.

Additional Resources
The program details can be found here

If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Derek Warnick (derek.warnick@pfizer.com), with the subject line “Vaccine Preventable Diseases – COVID-19”.

Please click here or visit: https://pfe-pfizercom-prod.s3.amazonaws.com/CompetitveGrantProgram_FrequentlyAskedQuestions.pdf to view Frequently Asked Questions regarding the Competitive Grant Program.

Tags
SOSCIP COVID-19 Response - Call for Applications

In response to the COVID-19 pandemic, Ontario-based industries and academic institutions are coming together to form strategies and provide support to fight this ongoing global crisis. As such, the work that needs to be done in advanced manufacturing, bioinformatics, molecular modelling, vaccine development and epidemiology demands considerable computational capacity.

The SOSCIP COVID-19 Response aims to provide rapid access to high-performance computing (HPC) resources on their advanced computing platforms. Through industry-academic partnerships, compute space for collaborators committed to responding to COVID-19 will be fast-tracked, and successful applicants will be rapidly launched onto the compute systems.

SOSCIP COVID-19 Response Details
Include a brief description of

  • Your COVID19 solution,

  • Your compute needs,

  • Your organization,

  • Your academic / industry partner.

Contact SOSCIP: covid.response@soscip.org

If your application is eligible, they will send you a formal application form for you to fill out.

For complete program information, please visit: https://www.soscip.org/covid19/#

Please note:  As indicated above, the applicant must also upload and submit the application through the university's My Research Application (MRA) System. The MRA approval process should be started well in advance in parallel to ensure a successful submission since it can take several business days to complete the approval process.

SSHRC Partnership Engage Grant

The Social Sciences and Humanities Research Council (SSHRC) is pleased to announce the partnership Engage Grants.  These grants are expected to respond to the objectives of the Insight program and the Connection program. Please note that Partnership Engage Grants cannot respond exclusively to the objectives of the Connection program.

These grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. The small-scale, stakeholder-driven partnerships supported through Partnership Engage Grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. In addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.

Sponsor Deadlines: December 15, March 15, June 15 by 8pm EST.

SSHRC Partnership Engage Grants COVID-19 Special Initiative

SSHRC is developing initiatives to support the social sciences and humanities research community during this time of unprecedented disruption and distress. As part of this effort, we are pleased to announce the launch of a new initiative within our Partnership Engage Grants: the PEG COVID-19 Special Initiative.

The potential contributions of researchers from the humanities and social sciences, including Indigenous research, are considerable – from highlighting the lessons of history, to probing individual and group behaviour, to exploring possible responses in policy and practice from  all sectors and disciplines, be it education, arts, economics, etc.

The PEG COVID-19 Special Initiative provides short-term and timely support for small-scale, stakeholder-driven partnerships through Partnership Engage Grants (PEG). This Special Initiative will allow researchers and their partners the possibility to address urgent and specific needs, as well as challenges or opportunities through collaborations. It will also provide a unique opportunity to foster knowledge exchange between postsecondary researchers and different sectors of society while including students, PhDs, PDFs and other HQPs on the COVID-19 crisis related issues, challenges and impacts.

SSHRC is committed to investing up to $1.5 M over the next two PEG competitions to support COVID-19 related projects. Grants are valued at a maximum amount of $25K per project for duration of one year.

Value $7,000 to $25,000
Duration 1 year
Application deadline 8 p.m. (eastern) on June 15 and September 15

Further details, including application information, are available on SSHRC’s website at the following link: https://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/peg-sep-covid-19-eng.aspx

SSHRC Partnership Programs Webinar

SSHRC Partnership Programs Webinar
Thursday, May 28, 2020
1:00-2:30 p.m.

This webinar will provide an overview of the SSHRC Partnership Program opportunities:

  • Partnership Engage Grants - provide short-term, timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. These one-year projects are meant to respond to immediate needs/opportunities and time constraints facing organizations in non-academic sectors.
  • Partnership Development Grants -provide support over one to three years to teams/partnerships, led by a project director, to:
         - develop research and related activities in the social sciences and humanities by fostering new partnerships for research and related activities
              involving existing and/or potential partners; or

         - design and test new partnership approaches for research and/or related activities that may result in best practices or models that either can be
              adapted by others or have the potential to be scaled up to a regional, national or international level.
  • Partnership Grants -  provide support for new and existing formal partnerships over four to seven years to advance research, research training and/or knowledge mobilization in the social sciences and humanities through mutual co-operation and sharing of intellectual leadership, as well as through resources as evidenced by cash and/or in-kind contributions.

Professor Shelley Stagg-Peterson, a recent Partnership Grant selection committee member, will discuss the adjudication process and the elements of a strong proposal. There will also be advice on partnership planning and proposal development from members of the Research Services team.

Learning Outcomes

Attendees can expect to increase their knowledge of:

  • SSHRC programs that support partnership-based research, and how these relate to other SSHRC funding opportunities  
  • Key features of these funding opportunities and the application processes  
  • Proposal evaluation criteria and the adjudication process  
  • Insights from a Partnership Grant holder and member of the Selection Committee  
  • Approaches and strategies for partnership planning and development  
  • Proposal development strategies   
  • Resources, tools and support for partnership planning and proposal development

Event Registration
Please visit the event page in EVE for webinar details and registration.

United States Department of Defense (DOD) - Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health

The PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care in one or more Focus Areas published in this Funding Opportunity for the FY20 PRMRP Topic Areas of Emerging Viral Diseases and/or Respiratory Health.
The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. Applications must include relevant data that support the rationale for the proposed study. These data may be unpublished or from the published literature.
Impact: The Investigator-Initiated Research Award is designed to support research with the potential to yield highly impactful data that could lead to critical discoveries or major advancements. The application must clearly demonstrate the project’s potential short-term and long-term outcome(s)/product(s) (knowledge and/or materiel) and how they will impact a critical problem or question in the field of research and/or patient care in one or more Focus Areas published in this funding opportunity for the FY20 PRMRP Topic Area(s) of Emerging Viral Diseases and/or Respiratory Health.
Research projects may focus on any phase of research from basic laboratory research through translational research, including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial. Research involving human subjects and human anatomical substances is permitted; however, this award may not be used to conduct clinical trials. For more information on how to distinguish clinical research from clinical trials, see the Human Subject Resource Document at https://ebrap.org/eBRAP/public/Program.htm.

Eligibility
PIs at or above the level of Assistant Professor (or equivalent) may be named by the organization as the PI on the application.
There are no limitations on the number of applications for which an investigator may be named as a PI. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization (University of Calgary is Eligible for this competition).

Submission Process

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), May 28, 2020
A pre-application must be submitted through eBRAP.org - please create an account at least one week prior to the pre-application submission deadline.
Application Submission Deadline: 11:59 p.m. ET, June 12, 2020
The Full Application is submitted by the University on the PI's behalf through Grants.gov - please create an account well in advance of the deadline to ensure it is linked to UofT.
Once your application is complete and finalized, press ‘Submit’.  Your application will be routed to the Research Services Office (RSO).  The final deadline for your submission of your application is NOON, 10 June 2020.
End of Application Verification Period: 5:00 p.m. ET, June 16, 2020
• Peer Review: July 2020

Programmatic Review: August 2020

United States Department of Defense (DOD) - Congressionally Directed Medical Research Programs - Funding Opportunities

US Department of Defense (DOD) Office of the Congressionally Directed Medical Research Programs (CDMRP) has released pre-funding announcements for the following programs:

Hearing Restoration Research Program (HRRP)

Focused Research Award

Neurotoxin Exposure Treatment Parkinson’s (NETP)

Early Investigator Research Award

Investigator-Initiated Research Award

Synergistic Idea Award (NEW!)

Prostate Cancer Research Program (PCRP)

Prostate Cancer Pathology Resource Network Award

*Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement at http://cdmrp.army.mil

Application Information:
UofT campus based applicants should select Toronto, University of for the institution and indicate the appropriate Research Services Office contact (see below) as the Business Official in their pre-application in the eBRAP System.  

Contact Information:
Krista Montgomery (krista.montgomery@utoronto.ca): for UofT Faculty appointed within Dalla Lana, Applied Sci & Eng, Dentistry, Forestry, Kinesiology & PE, Nursing, Pharmacy, UTM, and Medicine (last names A-M only).

Deadlines: Individual deadlines available at http://cdmrp.army.mil

University of Toronto Early Stage Technology Program (UTEST)

University of Toronto Early Stage Technology Program (UTEST) Applications due June 5th, 2020. 

The UTEST Program is announcing its ninth call for UofT companies. UTEST provides UofT start-up companies with seed funding of up to $150,000 in the form of a SAFE, 12 months of incubation space*, intense entrepreneurial education provided by MaRS, corporate and intellectual property legal support, mentoring and business strategy support. Our program partner, TIAP, provides sector expertise, an Entrepreneurs-in-Residence (EIR) program and follow-on investment capital of up to $500,000.

Since 2012 UTEST companies have raised over $250M in follow-on investment funding. 

Full program information and application can be found on the UTEST program page: http://www.utest.to

Applications are due before 11:59PM on June 5th, 2020.

Selected companies will be interviewed on June 9th and 10th. The program will begin the week of June 15th, 2020.

*UTEST will be operating in a remote capacity in the short term without access to the incubation space.

 Graduate Students & Postdoctoral Fellows

Award Explorer

Interested in awards at the University of Toronto? Whether you’re thinking of coming to U of T – or you are a current student pursuing undergraduate or graduate studies – this tool can help you explore the diverse funding opportunities that recognize your achievements and financially support your studies.

Graduate and Postdoctoral Awards database is available here.

Baxter Young Investigator Awards

The Baxter Young Investigator Awards (BYIA) is an annual program sponsored by Baxter to support and promote innovative research applicable to the development of our critical therapies and clinical diagnostics. BYIA is open to graduate students and postdoctoral fellows in North America.

Baxter's Young Investigator Awards seek to stimulate and reward research applicable to the development of therapies and medical products that save and sustain patients' lives. They  invite current graduate students and postdoctoral fellows to submit descriptions of ongoing research. The Baxter Young Investigator Awards program consists of two tiers: first-tier awards include a $3,000 cash prize and an onsite visit to Baxter to present the award-winning research; second-tier awards receive a $500 cash prize. Prizes are granted based on merit of the research.

Application Deadline

Research abstracts, resumes, and cover letters must be submitted via the online submission system (see link below) by no later than June 30, 2020. Incomplete application submissions will not be considered for awards.

To apply, please submit the following:

Baxter Young Investigator Awards Application
Advisor Letter

 

This webpage provides the scope & criteria for the awards, as well as detailed eligibility requirements and conditions. It also provides links to past winners and their research titles.

To obtain more information, please visit the BYIA website: https://www.baxter.com/our-story/fueling-collaborative-innovation/baxter-young-investigator-awards

Mitacs Globalink Research Award – Call for Applications

Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
Award amount: $6,000 Canadian for 12-24 week long research projects*
Application deadline: 3 months prior to student arriving at host university
Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
Application process: https://learningabroad.utoronto.ca/funding/gra/
Contact: mahvish.wesley@utoronto.ca

Mitacs Accelerate Graduate Student Internships

The Mitacs Accelerate program can help fund your research and trainee costs!   The Mitacs Accelerate program helps fund partnered research projects by supporting Masters, PhD students, or PostDocs through "units" consisting of 4-month paid graduate student internships.   Each Mitacs Accelerate grant is a $15,000 award, with at least $10,000 to support the student stipend and the balance available for project resources.  In addition to single awards, the program can support “clusters” of units that can span multiple years and dozens (or more) of pre-approved internship opportunities.  No deadlines - apply at any time.

Mitacs is a national funding agency and their programs can help you connect with industry, not-for-profit, community and other external partners.  

For information about the Mitacs Accelerate program, please see: Mitacs Accelerate
For general information on Mitacs, please see: https://www.mitacs.ca/en/about

Contact innovations.partnerships@utoronto.ca for more information on the internal process.

Mitacs Elevate - Postdoc Funding

Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Fellows address complex challenges through:

An exclusive research management curriculum for postdoctoral fellows in any discipline A minimum one-year research project (normally two years in duration) with a partner organization in need of high-level expertise A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value      

 

Please note: By the internal deadline, the applicant must upload and submit the application through the university's My Research Application (MRA) System. The MRA approval process should be started well in advance of the internal deadline to ensure a successful submission since it can take several business days to complete the approval process.

INTERNAL:
Application – July 15, 2020

For full detailed application information, please visit:https://research.utoronto.ca/funding-opportunities/db/mitacs-elevate-postdoctoral-fellowship

Key Deadlines:
 MITACS

Intent to Apply (non-mandatory) and Conflict of Interest Declaration (if applicable) - June 10, 2020 Application - July 22, 2020

NEW: Mitacs now accepts cross-provincial Elevate applications, where the partner and university are in different provinces.

Elevate fellows progress through the program in a cohort, giving them cross-disciplinary networking and peer-learning opportunities they might not have otherwise in their careers.

Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor.

Elevate fellows receive:

$55,000 minimum annual stipend/salary  (of the $60,000 awarded to the University; $5,000 being available to the supervisor's account, to support the research) Training curriculum valued at $7,500 per year Submission assistance, including application feedback, from Mitacs representatives Certificate of completion after receipt of their exit survey and final report submission

Undergraduate Students

Award Explorer

Interested in awards at the University of Toronto? Whether you’re thinking of coming to U of T – or you are a current student pursuing undergraduate or graduate studies – this tool can help you explore the diverse funding opportunities that recognize your achievements and financially support your studies.

Undergraduate Awards database is available here.

Mitacs Globalink Research Award – Call for Applications

Mitacs Globalink Research Award – Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
Award amount: $6,000 Canadian for 12-24 week long research projects*
Application deadline: 3 months prior to student arriving at host university
Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
Application process: https://learningabroad.utoronto.ca/funding/gra/
Contact: mahvish.wesley@utoronto.ca

Mitacs - Globalink Research Internship Summer of 2021 Call for Applications

The Mitacs Globalink Research Internship is a competitive initiative for international undergraduates from the following countries and regions: Australia, Brazil, China, France, Germany, Hong Kong SAR, India, Mexico, Tunisia, United Kingdom, USA, and Ukraine. From May to October of each year, top-ranked applicants participate in a 12-week research internship under the supervision of Canadian university faculty members in a variety of academic disciplines, from science, engineering and mathematics to the humanities and social sciences.

  • All disciplines are eligible
  • Faculty can submit multiple projects and re-submit projects from previous years

Internal Deadline: June 3, 2020
External Deadline: June 10, 2020, at 1 p.m. PT.

For detailed application information, please visit: Mitacs Globalink Research Internships 2021